181 related articles for article (PubMed ID: 23147603)
1. [Current aspects of obstetric ultrasound in the screening setting].
Tutschek B; Tercanli S
Praxis (Bern 1994); 2012 Nov; 101(23):1473-80. PubMed ID: 23147603
[TBL] [Abstract][Full Text] [Related]
2. First-trimester Ultrasound and Aneuploidy Screening in Multifetal Pregnancies.
Hirshberg A; Dugoff L
Clin Obstet Gynecol; 2015 Sep; 58(3):559-73. PubMed ID: 26133496
[TBL] [Abstract][Full Text] [Related]
3. Nuchal translucency measurement in first trimester Down syndrome screening.
Scott A
Issues Emerg Health Technol; 2007 Jun; (100):1-6. PubMed ID: 17595751
[TBL] [Abstract][Full Text] [Related]
4. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
5. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
6. Assessment of fetal malformations in the first trimester of pregnancy by three-dimensional ultrasonography in the rendering mode. Pictorial essay.
Araujo Júnior E; Rolo LC; Tonni G; Haeri S; Ruano R
Med Ultrason; 2015 Mar; 17(1):109-14. PubMed ID: 25745664
[TBL] [Abstract][Full Text] [Related]
7. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
[TBL] [Abstract][Full Text] [Related]
9. Optimal crown-rump length for measuring the nuchal translucency.
Wax JR; Pinette MG; Cartin A; Blackstone J
J Clin Ultrasound; 2007; 35(6):302-4. PubMed ID: 17486568
[TBL] [Abstract][Full Text] [Related]
10. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
[TBL] [Abstract][Full Text] [Related]
11. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment.
Orlandi F; Bilardo CM; Campogrande M; Krantz D; Hallahan T; Rossi C; Viora E
Ultrasound Obstet Gynecol; 2003 Jul; 22(1):36-9. PubMed ID: 12858300
[TBL] [Abstract][Full Text] [Related]
12. Fetal echocardiography at the time of the nuchal translucency scan.
Lombardi CM; Bellotti M; Fesslova V; Cappellini A
Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
[TBL] [Abstract][Full Text] [Related]
13. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
14. Targeted depiction of the fetal corpus callosum with 3D-ultrasound.
Merz E
Ultraschall Med; 2010 Oct; 31(5):441. PubMed ID: 20922604
[No Abstract] [Full Text] [Related]
15. [Recommendations for 3 D ultrasound in pregnancy. Expert correspondence no. 17 of 29 December 2006]].
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):99-100. PubMed ID: 17440272
[No Abstract] [Full Text] [Related]
16. Comparison between two- and three-dimensional ultrasound measurements of nuchal translucency.
Clementschitsch G; Hasenöhrl G; Schaffer H; Steiner H
Ultrasound Obstet Gynecol; 2001 Nov; 18(5):475-80. PubMed ID: 11844167
[TBL] [Abstract][Full Text] [Related]
17. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
Benacerraf BR
Prenat Diagn; 2010 Jul; 30(7):644-52. PubMed ID: 20572106
[TBL] [Abstract][Full Text] [Related]
18. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
[TBL] [Abstract][Full Text] [Related]
19. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
20. Reference ranges and distribution of placental volume by 3-dimensional virtual organ computer-aided analysis between 11 weeks and 13 weeks 6 days.
Guyomard A; Macé G; Ferdynus C; Franceschini C; Rousseau T; Sagot P
J Ultrasound Med; 2013 Aug; 32(8):1477-82. PubMed ID: 23887959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
